The class of MAGI-3 Activators primarily includes compounds that indirectly influence the activity of the MAGI-3 protein by modulating associated signaling pathways. These compounds act through various mechanisms to affect pathways that MAGI-3 is a part of, rather than directly binding to or altering MAGI-3 itself. For example, compounds like Forskolin elevate cAMP levels, which can indirectly influence the signaling environment where MAGI-3 operates. Similarly, inhibitors of signaling molecules such as PI3K (LY294002 and Wortmannin), MEK (PD98059, U0126, and AZD6244), p38 MAPK (SB203580), JNK (SP600125), mTOR (Rapamycin), AKT (GSK690693), and Wnt (Wnt3a and IWP-2) can modulate pathways in which MAGI-3 is implicated.
These compounds, through their modulation of specific signaling molecules or pathways, can indirectly influence the activity, localization, or the functional outcomes associated with MAGI-3. This indirect modulation is crucial in contexts where MAGI-3 plays a role in cellular processes like signal transduction, cell proliferation, and apoptosis. Since MAGI-3 is a scaffolding protein, its function is closely tied to the proper assembly and regulation of multi-protein complexes. By influencing the signaling environment or specific pathways, these compounds can alter the dynamics of such complexes, thereby modulating the activity or function of MAGI-3 within the cell. This highlights the complex interplay between various signaling molecules and pathways in determining the activity and function of scaffolding proteins like MAGI-3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, indirectly affecting pathways associated with MAGI-3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, can alter signaling pathways involving MAGI-3. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, influences pathways related to MAGI-3 by modulating ERK/MAPK signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, affects pathways related to MAGI-3 by modulating stress response signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, can affect pathways involving MAGI-3 by modulating stress response and apoptosis. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
MEK inhibitor, influences pathways associated with MAGI-3 by affecting ERK/MAPK signaling. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
AKT inhibitor, can modulate signaling pathways involving MAGI-3. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Wnt pathway inhibitor, affects MAGI-3-associated signaling by modulating Wnt activity. | ||||||